-
Mashup Score: 6Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants - 8 month(s) ago
The American Journal of Hematology publishes research in blood diseases in humans & animal model, covering all hematological diseases including leukemia, hemostasis and thrombosis.
Source: onlinelibrary.wiley.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 6Orbital Tumor in a 62-year-old Patient - 8 month(s) ago
A 62-year-old man presented with progressive ptosis of the left eyelid, which he had been experiencing for the past year. He had no other symptoms or significan
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 13
Drs. Lane, Konopleva, Taylor, and Guzman join the HemeReports team to discuss BPDCN
Source: ZoomCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Target Cells - 9 month(s) ago
Shoot for 150-160 chars
Source: imagebank.hematology.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Hemoglobin C crystals - 1. - 9 month(s) ago
Shoot for 150-160 chars
Source: imagebank.hematology.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 10Join our Cloud HD Video Meeting - 9 month(s) ago
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, conference, huddle, and training rooms, as well as executive offices and classrooms. Founded in 2011,…
Source: Zoom VideoCategories: Hem/Oncs, Latest HeadlinesTweet-
Dr. Yiannis Dimopoulos & I have 3 intriguing cases prepared for discussion. Spoiler alert 🚨: monocytic theme #hemepathMDA BM unknown, this Wednesday. Join us 🔬❓ Meeting: https://t.co/SCCphOqZYn ID: 843 3867 7292 Code: 660673 Slides: https://t.co/pg0AiKZcC9 👇🏻#hemepath https://t.co/Zi9klPwmMD https://t.co/MPuHLkSnEI
-
-
Mashup Score: 6Courses Archive - Area9 Lyceum - 9 month(s) ago
Courses for the seven sections are based on curricula that are used by experienced and board-certified professionals from the various disciplines in laboratory medicine. Each course consists of three separate components: learning objectives, probes, and learning resources. Learning objectives are granular and utilize Bloom’s taxonomy. They range in complexity from describe or define to deduce and analyze. Each course contains 100-150 learning objectives to cover the topic of interest. There are nine
Source: area9lyceum.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Hello #PathX #PathTwitter #MLSX #MLSTwitter #HemeX #HemeTwitter have you seen these @Clin_Chem_ADLM Adaptive Learning #LearningLab Courses on Bone Marrow and Peripheral Blood morphology? Check them out (FREE REGISTRATION) here: https://t.co/agW2v6bLTs #hemepath #leusm #lymcm… https://t.co/R2geNWSmYk https://t.co/BF1hhys0Ry
-
-
Mashup Score: 2HemeReports S2 E1 - 9 month(s) agoSource: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 7
World-renowned experts in the management of hematologic malignancies present the latest treatment advances, updates to the standard of care as recommended in the NCCN Guidelines®, and unique and challenging patient cases. Chaired by Andrew D. Zelenetz, MD, PhD, from Memorial Sloan Kettering Cancer Center, this program features presentations and interactive discussions highlighting the treatment…
Source: web.cvent.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
The HemeReports team talks with Dr. Elias Jabbour, Dr. Lori Muffly and Dr. Charles Mulligan.
Source: ZoomCategories: Hem/Oncs, Latest HeadlinesTweet-
We’re back with Season 2 of #HemeReports …. Opening the season with the Bs and Ts (ALL) Tune in for the discussion with our all star line up of experts….See you next week. Register here: https://t.co/T2mdqQ7Or7 #hemepath #leusm #endcancer #PathX #PathTwitter https://t.co/xSvlkqKIW6 https://t.co/L1ABHzymIg
-
Out today!! Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants @AjHematology #hemepath #leusm #germline @MDAndersonNews https://t.co/hRRoSOSLA4